1. Introduction {#sec1}
===============

Less than 1% of all cancers and primary hyperparathyroidism (PHPT) can be attributed to parathyroid carcinoma (PC) \[[@B1], [@B2]\]. The vast majority of cases are sporadic, whereas the rest occur in the context of genetic syndromes such as multiple endocrine neoplasia type 1 (MEN1) or hyperparathyroidism-jaw tumor syndrome (HPT-JT) \[[@B3], [@B4]\]. It has equal frequency in both genders and usually occurs during the fifth decade of life \[[@B1], [@B2]\]. Very high serum levels of intact parathyroid hormone (iPTH) and severe hypercalcemia are the main biochemical findings and clinical manifestations are due to its excessive secretion \[[@B5], [@B6]\]. It is usually diagnosed postoperatively with histology assessment given its absence of specific clinical and biochemical features \[[@B2]\].

Papillary thyroid cancers (PTCs) account the majority (80--85%) of thyroid cancer cases, specifically papillary thyroid microcarcinomas (PTMs) \[[@B7]--[@B9]\]. Radiation exposure and genetics are the known risk factors for PTCs. However, only 5% of PTC cases account for familial PTC \[[@B10]\]. It occurs predominantly in female, and the median age at presentation is 50 years \[[@B11]\]. An asymptomatic thyroid mass is usually the main clinical finding, and it can be accompanied with or without cervical lymph node enlargement. However, vocal cord paralysis and tracheal compression can be present in about 20% of PTC cases, and it is manifested as hoarseness and dysphagia \[[@B12]\]. Biochemical tests are of limited usefulness because most patients have normal thyroid function \[[@B13]\].

The coexistence of thyroid and parathyroid carcinoma is extremely infrequent. Here, we describe a patient with this unusual presentation.

2. Case Presentation {#sec2}
====================

A 50-year-old female without significant past medical or family history and no previous trauma presented with pain on her left heel that prompted her to seek medical attention. Initial evaluation was notable for serum concentration of calcium 14.3 mg/dL (normal range 8.6--10.3 mg/dL), alkaline phosphatase of 339.4 U/L (normal range 34--104 U/L), creatinine of 1.8 mg/dL (normal range 0.3--0.7 mg/dL), and iPTH level of 1160 pg/mL (normal range 12--88 pg/mL). Biochemical data of the patient are summarized in [Table 1](#tab1){ref-type="table"}. Because of the concern for chronic kidney disease, a renal ultrasound was performed and showed both kidney medullary nephrocalcinosis and thinning of the renal parenchyma. Bone densitometry revealed osteoporosis at the anteroposterior spine (T score −2.7) and femoral neck (T score −2.9) and osteopenia at the total hip (T score −2.3). A presumptive diagnosis of parathyroid carcinoma (PC) was made and referred to endocrinology department for further evaluation. Physical examination revealed a hardened and painless nodule at the left thyroid lobe without vocal cord paralysis. Thyroid function test values were within the reference ranges.

A 99mTc-sestamibi dual-phase fusion imaging with single-photon emission computed tomography/computed tomography (SPECT/CT) was performed, and a possible left-sided inferior parathyroid was identified ([Figure 1(a)](#fig1){ref-type="fig"}). Neck ultrasonography showed a 1.4 cm heterogeneous nodule and central vascularity in the middle-third of the left thyroid gland (Figures [2(a)](#fig2){ref-type="fig"} and [2(b)](#fig2){ref-type="fig"}). At the same area depicted by SPECT/CT, a 1.9 cm vascularized and hypoechoic oval nodule was present and considered likely to represent a parathyroid adenoma ([Figure 1(b)](#fig1){ref-type="fig"}). Due to its clinical context (severe hypercalcemia and very high levels of PTH), PC was suspected although imaging studies were not characteristic. At surgical intervention, a normal-appearing inferior parathyroid gland was identified and preserved in situ. An en bloc resection of the parathyroid mass and left thyroid lobe and central lymph node compartment dissection was performed. On the fourth postoperative day, the iPTH value was 84.6 pg/mL.

Gross examination of the surgical specimen revealed a 4.8 × 2.6 × 2.3 cm left thyroid lobe and a 2.4 × 1.8 × 1.4 cm left superior parathyroid gland. Histological examination revealed a 1.3 × 1.2 cm mass at the left thyroid lobe consistent of PTC of classical subtype ([Figure 3](#fig3){ref-type="fig"}) and PC, 2.5 cm in widest tumor dimension, with capsular and vascular space invasion ([Figure 4](#fig4){ref-type="fig"}). Immunohistochemical staining was positive for cyclidin D1 and negative for parafibromin. Ki-67 index was 2%. Six examined lymph nodes from central compartment were negative for metastasis. Her thyroid carcinoma was staged pT1bN0M0 (TNM AJCC 2018).

On the sixth postoperative day, the patient presented hypocalcemic symptoms (calcium 6.9 mg/dL) consistent with hungry bone syndrome. She received intravenous and oral calcium and vitamin D supplementation. Subsequently, she was discharged with oral calcium treatment and remained well, with the latest serum calcium level being 8.6 mg/dL (6 weeks postoperatively).

3. Discussion {#sec3}
=============

The simultaneous presence of thyroid and parathyroid carcinoma is extremely rare with only 15 documented cases \[[@B14]--[@B30]\] in the last 41 years, and no correlation, up to date, has been discovered between these entities \[[@B31]\]. Comparison of the previous cases and ours are described in [Table 1](#tab1){ref-type="table"}. The average age was 52 years (range 21--79), and the vast majority were female (80%). According to Surveillance, Epidemiology, and End Results (SEER) database, PTCs usually occur during the fourth and fifth decades of life and have a 2.5 : 1 female-to-male ratio \[[@B32]\], while the reported mean age for PC presentation was 44 to 45 years with an even distribution between genders \[[@B33]--[@B35]\]. As a result, the coexistence of thyroid and parathyroid carcinoma may have an impact on the gender distribution and age presentation. Notably, the youngest patient reported had Hürthle cell thyroid carcinoma and PC \[[@B21]\]. Hürthle cell carcinoma is associated with poorer prognosis and higher recurrence rate in local lymph nodes \[[@B36], [@B37]\].

Almost all patients had functional PC (including our patient) as outlined in [Table 2](#tab2){ref-type="table"}. Nonfunctional PC is much more infrequent than functional PC, and it has a decreased survival due to its absence of symptoms and perhaps to its aggressive biology \[[@B16], [@B39]\]. To our knowledge, only one case of nonfunctional PC occurring with PTM was reported \[[@B40]\]. Interestingly, all cases with reported PC localization including the one here reported had a preponderance for the left lower side.

A common but not diagnostic features of PC include trabecular architecture of the parenchymal cells, a thick capsule, fibrous trabeculae traversing the gland, nuclear atypia, and high mitotic rates \[[@B41]--[@B43]\]. Criteria for definitive diagnosis of PC consist of capsular and vascular invasion, adjacent tissues invasion, involvement of regional lymph nodes, and distant metastatic lesions. Because cell seeding can occur due to the rupture of capsule in the operative field, locally recurrent disease is not diagnostic. Our patient had a clear capsular and vascular invasion (Figures [2(b)](#fig2){ref-type="fig"} and [2(c)](#fig2){ref-type="fig"}), making the diagnosis of PC unequivocal. It has been reported that extracapsular vascular invasion correlates best with the diagnosis \[[@B33]\].

Risk factors for PC include history of neck irradiation, long-standing secondary hyperparathyroidism (HPT), end-stage renal disease, and hereditary HPT-jaw tumor syndrome. Additionally, mutation of parafibromin (HRPT2, also known as CDC73) and cyclin D1 (CCND1) plays an important role in the molecular pathogenesis of PC \[[@B1], [@B44], [@B45]\]. Our patient has no history of neck irradiation and has not underwent genetic testing.

Here, we describe a case of a PTH-secreting PC that had an appearance of parathyroid adenoma in imaging studies. It was suspected due to marked hypercalcemia and a very high iPTH and renal and bone disease. PTC was only diagnosed postoperatively with histological examination.

Radical surgery provides the best possibility of cure. However, more than 50% of the patients have persistent or recurrent disease. The main cause of morbidity and mortality is due to hypercalcemia complications \[[@B34]\] and less frequently to metastasis \[[@B46]\].

4. Conclusion {#sec4}
=============

The presented case emphasizes the requirement of high clinical suspicion of parathyroid carcinoma in the presence of very high level of iPTH, marked hypercalcemia, and overt skeletal and renal involvement. The existence of any thyroid nodules should be approached and coexistence of other carcinomas should be considered. Although imaging studies assist in the localization, reliable distinction of parathyroid carcinoma from adenoma cannot be made. Radical surgery is the only effective and curative treatment and should consist of initial en bloc resection of the tumor with ipsilateral thyroidectomy and central neck dissection.
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![(a, b) 99mTc-sestamibi dual-phase with single-photon emission computed tomography/computed tomography fused images, showing uptake within middle to inferior left lobe of the thyroid. (b, c) Ultrasonograms revealing an oval-shaped hypoechoic solid nodule (1.40 × 1.39 × 1.92 cm) at the same area.](CRIE2020-2128093.001){#fig1}

![(a, b) Ultrasonograms (transverse and sagittal views), demonstrating a fairly oval-shaped solid isoechoic nodule with mixed solid and cystic components (1.38 × 1.14 × 1.36 cm) in the middle portion of the left thyroid lobe.](CRIE2020-2128093.002){#fig2}

![(a) Histologic appearance of the 1.3 cm papillary carcinoma in the left thyroid lobe, demonstrating a cystic neoplasia with a papillary pattern in transition with residual thyroid normal tissue (hematoxylin-eosin stain original magnification ×4). (b) Histopathological section showing typical features of papillary carcinoma: fibrovascular stalk covered with follicular cells depicting eosinophilic cytoplasm follicular cells and oval nuclei (^*∗*^) with pseudoinclusions (blue arrow) (hematoxylin-eosin stain original magnification ×40).](CRIE2020-2128093.003){#fig3}

![(a) Histology appearance of parathyroid carcinoma in transition with papillary thyroid carcinoma removed from the left thyroid lobe. The neoplastic cells are represented by the monomorphic cellular proliferation with discrete atypia and mitosis (hematoxylin-eosin stain original magnification ×4). (b) Histopathologic section demonstrating capsular invasion and (c) vascular invasion (hematoxylin-eosin stain original magnification ×10).](CRIE2020-2128093.004){#fig4}

###### 

Laboratory at admission and at two months postoperative.

  Laboratory values (normal range)     At admission   At two months postoperatively
  ------------------------------------ -------------- -------------------------------
  Calcemia (8.6--10.3 mg/dL)           14.3           9.5
  Ionized calcemia (4.36--5.2 mg/dL)   7.06           4.83
  Magnesium (1.9--2.7 mg/dL)           2.1            1.94
  Creatinine (0.3--0.7 mg/dL)          2              1.77
  Albumin (3.5--5.7 g/dL)              3.68           3.24
  Alkaline phosphatase (34--104 U/L)   381            399
  PTH (12--88 pg/mL)                   1160           7.4
  Phosphatemia (2.5--5 mg/dL)          2.73           3.28
  25(OH) vitamin D (30--100 ng/mL)     10.1           43
  FT4 (0.63--1.34 ng/dL)               0.72           0.97
  T3T (0.64--1.81 ng/mL)               1.07           0.79
  TSH (0.3--5 mIU/L)                   1.8            4.14

###### 

Clinical and biochemical features of 15 patients with coexistence of parathyroid and thyroid carcinoma.

  Reference                               Age   Gender   Calcium (mg/dL)   PTH (pg/mL)   Parathyroid gland size (cm)   Carcinoma location   Thyroid carcinoma          Associated parathyroid disease                          Surgical treatment                                                                                                               Outcome
  --------------------------------------- ----- -------- ----------------- ------------- ----------------------------- -------------------- -------------------------- ------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------
  Kurita et al. \[[@B38]\]                68    F        12.2              6300          4.2 × 3.2 × 2.4               Left lower           Papillary                  None                                                    En bloc resection                                                                                                                Postoperative normocalcemia
  Christmas et al. \[[@B26]\]             62    F        Hypercalcemia     Unknown       Unknown                       Unknown              Follicular                 None                                                    Unknown                                                                                                                          Died from metastatic parathyroid carcinoma
  Savli et al. \[[@B22]\]                 47    F        Normal            Normal        Normal                        Unknown              Papillary                  Hyperplasia                                             Total thyroidectomy parathyroidectomy (excision of 2 hyperplastic glands)                                                        Normocalcemia (1 year)
  Bednarek-Tupikowska et al. \[[@B27]\]   42    F        15.4              1655          5 cm in diameter              Left lower           Follicular                 None                                                    En bloc resection                                                                                                                Persistent hypercalcemia
  Schoretsanitis, 2002 \[[@B24]\]         55    F        14.2              \>1000        3 × 3                         Left lower           Papillary                  None                                                    En bloc resection                                                                                                                Normocalcemia (6 years)
  Kern et al. \[[@B28]\]                  54    F        Unknown           465           2.5 × 1.8 × 1.6               Right lower          Papillary and follicular   None                                                    Right parathyroidectomy; total thyroidectomy with local lymph node resection; corticectomy in the right superior frontal gyrus   Died from intracranial metastatic parathyroid carcinoma
  Lin et al. \[[@B25]\]                   38    M        16.5              351           4 × 3 × 3                     Left lower           Papillary                  Two enlarged parathyroid glands on contralateral side   Total thyroidectomy and left parathyroidectomy                                                                                   Normocalcemia (6 years)
  Goldfarb et al. \[[@B16]\]              58    M        14.4              2023          3.4 × 3.3 × 2.2               Left lower           Papillary                  Contralateral parathyroid adenoma                       En bloc resection                                                                                                                Persistent hypercalcemia after resection of parathyroid carcinoma; normocalcemia after excision of contralateral parathyroid adenoma (1 year)
  Marcy et al. \[[@B17]\]                 42    F        14.1              383           1.3                           Right lower          Papillary                  None                                                    Total thyroidectomy, right parathyroidectomy, and central and lateral neck dissection                                            Normocalcemia (14 months)
  Chaychi et al. \[[@B18]\]               79    F        10.4              89            1.1 × 1.2 × 4.8               Left superior        Papillary                  None                                                    Total thyroidectomy and left parathyroidectomy                                                                                   Normocalcemia (6 months)
  Amoodi et al. \[[@B19]\]                48    F        Unknown           186           \>5                           Left lower           Papillary                  None                                                    En bloc resection                                                                                                                Persistent hypercalcemia after resection of parathyroid carcinoma; hypoparathyroidism after completion of parathyroidectomy
  Zakerkish et al. \[[@B21]\]             21    M        13                1311          Unknown                       Unknown              Hürthle                    None                                                    Total thyroidectomy and parathyroidectomy                                                                                        Persistent hypercalcemia and died due to its complications
  Song et al. \[[@B30]\]                  45    F        17                1455          4.28 × 3.09 × 2.54            Left lower           Papillary                  None                                                    Left parathyroidectomy and left thyroid lobectomy plus left neck dissection                                                      Persistent hypercalcemia after left parathyroidectomy; normocalcemia after left thyroid lobectomy plus left neck dissection (6 months)
  Baek et al. \[[@B23]\]                  68    F        12.8              1247          4.2 × 3.3 × 3.1               Left lower           Papillary                  None                                                    Left inferior parathyroidectomy and left thyroid lobectomy                                                                       Postoperative normocalcemia
  Kuzu et al. \[[@B29]\]                  52    F        11.4              208           Unknown                       Unknown              Papillary                  None                                                    Right parathyroidectomy and right thyroid lobectomy                                                                              Postoperative normocalcemia
  Our case                                50    F        13.9              1160          2.4 × 1.8 × 1.4               Left superior        Papillary                  None                                                    Left inferior parathyroidectomy and left thyroid lobectomy                                                                       Postoperative normocalcemia
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